Menu
Recruiting NCT04707781

Database for Interstitial Lung Disease

— Observational Lung Diseases, Interstitial

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: chest CT.
Who it may be relevant to
Registry conditions: Lung Diseases, Interstitial. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Austria
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Clinical Database for the Early Recognition of Pulmonary Parenchymal Involvement in Patients With Systemic Diseases Bearing a Risk for Interstitial Lung Disease

Overview

The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.

Interventions

  • Diagnostic test chest CT
    assessment of interstitial lung disease using chest CT

Primary outcome measures

  • DLCO%pred (carbon monoxide diffusing capacity) at time of ILD diagnosis [Time frame: 5 years]
Secondary outcome measures (1)
  • FVC%pred (Forced vital capacity) at time of ILD diagnosis [Time frame: 5 years]

Eligibility criteria

Inclusion criteria

  • Age: ≥ 18 years
  • patients with a known systemic disease bearing a risk for ILD
  • signed informed consent (for prospective part)

Exclusion criteria

  • Age < 18 years
  • comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Austria · 1 center
  • Medical University of Graz, Department of Internal Medicine, Division of Pulmonology — Graz

Identifiers

NCT: NCT04707781 · 33-023 ex 20/21

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗